Zain Khalpey/LinkedIn
Dec 19, 2025, 09:24
Zain Khalpey on A New Study Linking Low-dose Aspirin to Reduced Cancer Spread
Zain Khalpey, Adjunct Assistant Professor of Surgery at Columbia University Irving Medical Center, shared on LinkedIn:
”A paper in The New England Journal of Medicine outlines a mechanism by which low-dose aspirin may reduce cancer spread, particularly in colorectal cancer and in individuals with certain mutations or CHIP.
By lowering platelet activation and thromboxane A2 signaling, aspirin helps release T cells from immune suppression and supports antimetastatic immunity.
Follow Zain Khalpey for more on Ai and Healthcare.”
Read the full article in NEJM.
Article: Understanding How Aspirin Prevents Metastasis
Authors: Ruth E. Langley, John Burn
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 2, 2026, 13:08Hammam Alminshawi: Time is Brain – Optimizing MRI for Acute Ischemic Stroke
-
Feb 2, 2026, 12:53Lucie Gelon: Proud to Share My 1st Achievements in The Scientific and Platelet World
-
Feb 2, 2026, 12:32Matthew Flick on SARS-CoV-2 Spike Protein and Coagulation Biology
-
Feb 2, 2026, 11:24Shivanand Kumatagi Delivers an Interactive Session on ISBT128 Standard
-
Feb 2, 2026, 11:03Meghan Delaney Congratulates Ruchika Goel for The Recent Paper on Pediatric Transfusion
-
Feb 2, 2026, 10:31Fayad Al-Haimus: Is Giving TXA Within “3 Hours” Really Enough?
-
Feb 2, 2026, 10:07David Benito Laorga’s Haemophilia Team Hosts Hemosfera
-
Feb 2, 2026, 09:49Tichakunda Mharazanye: A New Year, New Challenges, And New Milestones
-
Feb 2, 2026, 09:16Eyiuche Ezigbo Calls for Stronger VWD Awareness and Better Care in LMICs